Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Sleep Medicine ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.Am J Respir Crit Care Med. 2013; 188: 996-1004
- A method for measuring and modeling the physiological traits causing obstructive sleep apnea.J Appl Physiol. 2011; 110: 1627-1637
- A simplified method for determining phenotypic traits in patients with obstructive sleep apnea.J Appl Physiol. 2013; 114: 911-922
- Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study.Arch Intern Med. 2005; 165: 2408-2413
- Raphe unit activity in freely moving cats: correlation with level of behavioral arousal.Brain Res. 1979; 163: 135-150
- Hypothalamic regulation of sleep and circadian rhythms.Nature. 2005; 437: 1257-1263
- Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats.J Physiol. 2001; 532: 467-481
- Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states.Am J Respir Crit Care Med. 2006; 174: 1264-1273
- Identification of the mechanism mediating genioglossus muscle suppression in REM sleep.Am J Respir Crit Care Med. 2013; 187: 311-319
- The effects of serotonin antagonists in an animal model of sleep-disordered breathing.Am J Respir Crit Care Med. 1996; 153: 776-786
- R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats.Pharmacol Biochem Behav. 2001; 69: 283-289
- The effects of ondansetron on sleep-disordered breathing in the English bulldog.Sleep. 2001; 24: 155-160
- Response of obstructive sleep apnea to fluoxetine and protriptyline.Chest. 1991; 100: 416-421
- Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea.Sleep. 1999; 22: 61-67
- Effect of ondansetron on moderate obstructive sleep apnoea, a single night, placebo-controlled trial.J Sleep Res. 2003; 12: 169-170
- Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome.Sleep. 2010; 33: 982-989
- Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea.Sleep. 2008; 3: 824-831
- Efficacy of mirtazapine in obstructive sleep apnea syndrome.Sleep. 2007; 30: 35-41
- The role of protriptyline in obstructive sleep apnea.Bull Eur Physiopathol Respir. 1983; 19: 621-624
- The effects of protriptyline in sleep-disordered breathing.Am Rev Respir Dis. 1983; 127: 8-13
- Protriptyline in the treatment of sleep apnoea.Thorax. 1982; 37: 49-53
- K+ channel modulation causes genioglossus inhibition in REM sleep and is a strategy for reactivation.Respir Physiol Neurobiol. 2013; 188: 277-288
- Identification of a pharmacological target for genioglossus reactivation throughout sleep.Sleep. 2014; 37: 41-50
- The influence of increasing ventilatory effort on arousal from sleep.Am Rev Respir Dis. 1990; 142: 295-300
- Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment.J Appl Physiol. 2014; 116: 302-313
- Trazodone increases the respiratory arousal threshold in patients with obstructive sleep apnea and a low arousal threshold.Sleep. 2014; 37: 811-819
- Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold.Clin Sci (Lond). 2011; 120: 505-514
- Effects of pentobarbital on upper airway patency during sleep.Eur Respir J. 2010; 36: 569-576
- A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.Sleep Med. 2007; 8: 464-470
- Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study.Eur Respir J. 1994; 7: 2011-2015
- The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease.Sleep Breath. 2009; 13: 79-84
- Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemoreflexes during wakefulness.J Sleep Res. 2011; 20: 526-532
- Effect of zopiclone on sleep, night-time ventilation, and daytime vigilance in upper airway resistance syndrome.Eur Respir J. 1997; 10: 2573-2577
- Chemical control stability in patients with obstructive sleep apnea.Am J Respir Crit Care Med. 2001; 163: 1181-1190
- Effects of hyperoxia and hypoxia on the physiological traits responsible for obstructive sleep apnoea.J Physiol. 2014; 592: 4523-4535
- The effect of low flow oxygen on sleep-disordered breathing and oxygen desaturation. A study of patients with chronic obstructive lung disease.Chest. 1980; 78: 682-685
- The effects of oxygen in patients with sleep apnea.Am Rev Respir Dis. 1984; 130: 958-963
- Effect of oxygen in obstructive sleep apnea: role of loop gain.Respir Physiol Neurobiol. 2008; 162: 144-151
- Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea.J Physiol. 2012; 590: 1199-2111
- Effects of medroxyprogesterone acetate in obstructive sleep apnea.Chest. 1986; 90: 815-821
- Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study.Chest. 2008; 133: 677-683
- A double-blind, randomized trial of sabeluzole–a putative glutamate antagonist–in obstructive sleep apnea.Sleep. 1996; 19: 287-289
Article info
Publication history
Published online: April 08, 2016
Footnotes
Conflicts of Interest: Chief Medical Officer: Apnicure Inc. Consultant: Philips Respironics. Consultant: LinguaFlex. Advisory Board: Night Balance.
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.